EIF4EBP2 and Parkinson disease: This principle also paves the way for monumental research on possible treatments for Parkinson’s by tying 4E-BP2 deamidation to the axon’s proteasome-poor nature because, as seen in previous literature [36], the first sign of Parkinson’s progression is the degradation of motor axons, which is tied to a change in protein production.